All In Biotech

Drug Trial Radar · NCT04598893

Recent-Onset Type 1 Diabetes Extension Study Evaluating the Long-Term Safety of Teplizumab (PROTECT Extension)

A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab (PRV-031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adolescents With Recent-Onset Type 1 Diabetes Mellitus

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

188

Actual

Start

Oct 26, 2020

Primary completion

Nov 12, 2026

Study completion Nov 12, 2026

Sponsor

Sponsor type
Industry
First posted
Oct 22, 2020

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 9 years, up to 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this non-interventional extension study is to continue to collect long-term safety and other clinical data for an additional 42 months in participants who completed the PROTECT study.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • TeplizumabBiological

    Received teplizumab in PROTECT Study

  • PlaceboOther

    Received placebo in PROTECT study

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of adverse events (AEs), serious adverse events (SAEs) and adverse events of special interest (AESIs), including infections and malignanciesTime frame: During 42 months of follow-up

Locations

47 sites in 8 countries. Site status is shown where the registry gives one.

  • Rady Children's Hospital 3020 Children's Way (Site 840004)

    San Diego, California

  • UCSF Medical Center Gateway Medical Building, 1825 Fourth Street (Site 840001)

    San Francisco, California

  • Diablo Clinical Research2255 Ygnacio Valley Road, Ste. M (Site 840002)

    Walnut Creek, California

  • Barbara Davis Center for Diabetes - Pediatrics 1775 Aurora Court (Site 840005)

    Aurora, Colorado

  • Nemours Children's Health, 807 Children's Way

    Jacksonville, Florida

  • Johns Hopkins All Children's Hospital, 501 6th Avenue South (Site 840048)

    St. Petersburg, Florida

  • Atlanta Diabetes Associates 1800 Howell Mill Road. Suite 450 (Site 840009)

    Atlanta, Georgia

  • Centricity Research (Site 840006)

    Columbus, Georgia

  • St. Luke's Children's Endocrinology, 305 E Jefferson St. (Site 840052)

    Boise, Idaho

  • Rocky Mountain Clinical Research, LLC 3910 Washington Parkway, Suite E (Site 840007)

    Idaho Falls, Idaho

  • Indiana University Hospital, Indiana Clinical Research Center, 550 North University Boulevard (Site 840014)

    Indianapolis, Indiana

  • University of Iowa Hospitals and Clinics 200 Hawkins Drive (Site 840023)

    Iowa City, Iowa

  • Capital Medical Research Associates (Site 840029)

    Camp Springs, Maryland

  • Baystate Medical Center, 759 Chestnut Street

    Springfield, Massachusetts

  • Children's Mercy Hospitals and Clinics, 2401 Gillham Road (Site 840026)

    Kansas City, Missouri

  • Washington University School of Medicine, Pediatric Clinical Research Unit, Suite 11W19 (Site 840018)

    St Louis, Missouri

  • UBMD Pediatrics 1001 Main Street, 4th Floor (Site 840010)

    Buffalo, New York

  • UNC Hospitals, The University of North Carolina at Chapel Hill, Children's Specialty Clinic, 101 Manning Drive (Site 840038)

    Chapel Hill, North Carolina

  • Endocrinology Service Northwest, LLC 929 SW Simpson Ave. Suite 220 (Site 840034)

    Bend, Oregon

  • Children's Hospital of Philadelphia, Division of Endocrinology 3500 Civic Center Blvd., Buerger Center 12th Floor (Site 840021)

    Philadelphia, Pennsylvania

  • AM Diabetes & Endocrinology Center, 3025 Kate Bond Rd. (Site 840008)

    Bartlett, Tennessee

  • Vanderbilt University Medical Center 1500 21st Avenue, Suite 1514, Village At Vanderbilt (Site 840024)

    Nashville, Tennessee

  • UT Southwestern Children's Medical Center of Dallas 1935 Medical District Drive (Site 840033)

    Dallas, Texas

  • Virginia Mason Medical Center, Benaroya Research Institute 1201 9th Ave, MS: D4-CRP (Site 840016)

    Seattle, Washington

  • MultiCare Health System, Gateway Medical Building (Site 840003)

    Tacoma, Washington

  • UCL Namur University Hospital Place Louise Godin 15 (Site 056205)

    Namur, Belgium

  • University Hospital Brussels (Site 056202)

    Jette, Brussels Capital, Belgium

  • Alberta Diabetes Institute, 2-004 Li Ka Shing Centre for Health Research Innovation 8602 (Site 124103)

    Edmundston, Alberta, Canada

  • BCDiabetes - Medical Research Center, 210 West Broadway Suite 400 (Site 124102)

    Vancouver, British Columbia, Canada

  • University Hospital Motol V Uvalu 84, Praha 5 - Motol (Site 203301)

    Prague, Czechia

  • Woman Mother Child Hospital HCL

    Bron, France

  • Dijon University Hospital Center-Francois Mitterand Hospital, Children's Hospital

    Dijon, France

  • CHU La Timone - La Timone Children's Hospital

    Marseille, France

  • Lenval Hospital, 57 Avenue de la Californie (Site 250508)

    Nice, France

  • Hospital Center Regional D'Orleans Hospital La Source, Pediatric Department, 14 Hospital Ave Post box 86709 (Site 250513)

    Orléans, France

  • Necker Children's Hospital, 149 Rue de Sevres (Site 250502)

    Paris, France

  • Pau Hospital Center

    Pau, France

  • Hospital Augsburg, Stenglinstrasse 2 (Site 276606)

    Augsburg, Germany

  • University Hospital Carl Gustav Carus Fetscherstrasse 74 (Site 276601)

    Dresden, Germany

  • Pediatric Hospital on the Bult Janusz-Korczak-Allee 12 (Site 276604)

    Hanover, Germany

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.